Lowenstein represented Cellular Longevity, Inc. (dba Loyal) in a $27 million Series A funding round, led by Khosla Ventures and including First Round Capital, Box Group, Collaborative Fund, The Longevity Fund and Lachy Groom — all companies involved in Loyal’s $11 million seed round raised in 2020, as well as a group of angel investors. To date, the company has raised $38 million since being founded in 2019 by founder and CEO Celine Halioua.

Loyal is building an animal pharmaceutical company that is developing therapeutics aimed at extending both lifespan and healthspan for dogs, utilizing companion dog citizen science studies of over 500 dogs to better understand dog aging and eventually parlay that R&D into products intended for humans.

The Lowenstein deal team included Kathi A. Rawnsley, Gwendolyn Holst, and Chad M.P. Weeks.

About Lowenstein Sandler LLP
Lowenstein Sandler is a national law firm with over 350 lawyers based in New York, Palo Alto, New Jersey, Utah, and Washington, D.C. The firm represents leaders in virtually every sector of the global economy, with particular emphasis on investment funds, life sciences, and technology. Recognized for its entrepreneurial spirit and high standard of client service, the firm is committed to the interests of its clients, colleagues, and communities.

Penny Paul
Senior Manager, Marketing Communications
Lowenstein Sandler LLP
(973) 597-2592